| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-06-08 |
4 |
AS |
$20.36 |
$185,276 |
D/D |
(9,100) |
402,901 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-22 |
4 |
AS |
$9.65 |
$2,191 |
D/D |
(227) |
403,368 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-19 |
4 |
AS |
$9.64 |
$20,614 |
D/D |
(2,138) |
403,595 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-18 |
4 |
AS |
$10.49 |
$2,853 |
D/D |
(272) |
405,733 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,900 |
406,005 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-11-27 |
4 |
AS |
$10.53 |
$1,927 |
D/D |
(183) |
409,305 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-11-26 |
4 |
AS |
$10.58 |
$2,179 |
D/D |
(206) |
409,488 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-11-20 |
4 |
AS |
$10.96 |
$2,313 |
D/D |
(211) |
409,694 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-28 |
4 |
AS |
$14.35 |
$2,612 |
D/D |
(182) |
409,905 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-23 |
4 |
AS |
$13.64 |
$2,810 |
D/D |
(206) |
410,087 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-21 |
4 |
AS |
$13.78 |
$2,908 |
D/D |
(211) |
410,293 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-29 |
4 |
AS |
$13.93 |
$2,535 |
D/D |
(182) |
410,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-23 |
4 |
AS |
$13.90 |
$2,891 |
D/D |
(208) |
410,686 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-21 |
4 |
AS |
$13.87 |
$2,927 |
D/D |
(211) |
410,894 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-28 |
4 |
AS |
$14.90 |
$2,712 |
D/D |
(182) |
411,105 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-24 |
4 |
AS |
$15.71 |
$12,238 |
D/D |
(779) |
411,287 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-05-26 |
4 |
AS |
$19.20 |
$3,494 |
D/D |
(182) |
412,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-23 |
4 |
AS |
$15.16 |
$1,546 |
D/D |
(102) |
412,066 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-22 |
4 |
AS |
$15.11 |
$3,188 |
D/D |
(211) |
412,168 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-05-24 |
4 |
AS |
$18.69 |
$1,906 |
D/D |
(102) |
412,183 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-05-20 |
4 |
AS |
$18.55 |
$3,951 |
D/D |
(213) |
412,285 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,473 |
412,379 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
412,498 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-15 |
4 |
AS |
$12.26 |
$10,274 |
D/D |
(838) |
415,667 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-12-20 |
4 |
OE |
$0.99 |
$7,128 |
D/D |
7,200 |
416,505 |
0 |
- |
|
173 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
